Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 625 to 632 of 632 entries
Sorted by: Best Match Show Resources per page
Evaluation of the Tyrosine and Dopamine Serum Levels in Experimental Infected BALB/c Mice with Chronic Toxoplasmosis.

Journal of parasitology research

Mirzaeipour M, Mikaeili F, Asgari Q, Nohtani M, Rashidi S, Bahreini MS.
PMID: 34447590
J Parasitol Res. 2021 Aug 17;2021:5511516. doi: 10.1155/2021/5511516. eCollection 2021.

RESULTS: Microscopic methods confirmed the formation of the CONCLUSIONS: No detection of tyrosine level in most of the sample groups is probably related to the very low concentration of tyrosine in sera. However, low concentration of tyrosine at day...

Cite
Mirzaeipour M, Mikaeili F, Asgari Q, et al. Evaluation of the Tyrosine and Dopamine Serum Levels in Experimental Infected BALB/c Mice with Chronic Toxoplasmosis. J Parasitol Res. 2021;2021:5511516doi: 10.1155/2021/5511516.
Mirzaeipour, M., Mikaeili, F., Asgari, Q., Nohtani, M., Rashidi, S., & Bahreini, M. S. (2021). Evaluation of the Tyrosine and Dopamine Serum Levels in Experimental Infected BALB/c Mice with Chronic Toxoplasmosis. Journal of parasitology research, 20215511516. https://doi.org/10.1155/2021/5511516
Mirzaeipour, Mehdi, et al. "Evaluation of the Tyrosine and Dopamine Serum Levels in Experimental Infected BALB/c Mice with Chronic Toxoplasmosis." Journal of parasitology research vol. 2021 (2021): 5511516. doi: https://doi.org/10.1155/2021/5511516
Mirzaeipour M, Mikaeili F, Asgari Q, Nohtani M, Rashidi S, Bahreini MS. Evaluation of the Tyrosine and Dopamine Serum Levels in Experimental Infected BALB/c Mice with Chronic Toxoplasmosis. J Parasitol Res. 2021 Aug 17;2021:5511516. doi: 10.1155/2021/5511516. eCollection 2021. PMID: 34447590; PMCID: PMC8384541.
Copy Download .nbib Format: NLM
Publisher Correction: Synbiotic feed supplementation significantly improves lipid utilization and shows discrete effects on disease resistance in rainbow trout (Oncorhynchus mykiss).

Scientific reports

Villumsen KR, Ohtani M, Forberg T, Aasum E, Tinsley J, Bojesen AM.
PMID: 33911169
Sci Rep. 2021 Apr 28;11(1):9479. doi: 10.1038/s41598-021-88891-4.

No abstract available.

Cite
Villumsen KR, Ohtani M, Forberg T, et al. Publisher Correction: Synbiotic feed supplementation significantly improves lipid utilization and shows discrete effects on disease resistance in rainbow trout (Oncorhynchus mykiss). Sci Rep. 2021;11(1):9479doi: 10.1038/s41598-021-88891-4.
Villumsen, K. R., Ohtani, M., Forberg, T., Aasum, E., Tinsley, J., & Bojesen, A. M. (2021). Publisher Correction: Synbiotic feed supplementation significantly improves lipid utilization and shows discrete effects on disease resistance in rainbow trout (Oncorhynchus mykiss). Scientific reports, 11(1), 9479. https://doi.org/10.1038/s41598-021-88891-4
Villumsen, Kasper Rømer, et al. "Publisher Correction: Synbiotic feed supplementation significantly improves lipid utilization and shows discrete effects on disease resistance in rainbow trout (Oncorhynchus mykiss)." Scientific reports vol. 11,1 (2021): 9479. doi: https://doi.org/10.1038/s41598-021-88891-4
Villumsen KR, Ohtani M, Forberg T, Aasum E, Tinsley J, Bojesen AM. Publisher Correction: Synbiotic feed supplementation significantly improves lipid utilization and shows discrete effects on disease resistance in rainbow trout (Oncorhynchus mykiss). Sci Rep. 2021 Apr 28;11(1):9479. doi: 10.1038/s41598-021-88891-4. PMID: 33911169; PMCID: PMC8081722.
Copy Download .nbib Format: NLM
Dynamic Properties of Particle Injections Inside Geosynchronous Orbit: A Multisatellite Case Study.

Journal of geophysical research. Space physics

Motoba T, Ohtani S, Claudepierre SG, Reeves GD, Ukhorskiy AY, Lanzerotti LJ.
PMID: 33282620
J Geophys Res Space Phys. 2020 Sep;125(9):e2020JA028215. doi: 10.1029/2020JA028215. Epub 2020 Sep 17.

Four closely located satellites at and inside geosynchronous orbit (GEO) provided a great opportunity to study the dynamical evolution and spatial scale of premidnight energetic particle injections inside GEO during a moderate substorm on 23 December 2016. Just following...

Cite
Motoba T, Ohtani S, Claudepierre SG, et al. Dynamic Properties of Particle Injections Inside Geosynchronous Orbit: A Multisatellite Case Study. J Geophys Res Space Phys. 2020;125(9):e2020JA028215doi: 10.1029/2020JA028215.
Motoba, T., Ohtani, S., Claudepierre, S. G., Reeves, G. D., Ukhorskiy, A. Y., & Lanzerotti, L. J. (2020). Dynamic Properties of Particle Injections Inside Geosynchronous Orbit: A Multisatellite Case Study. Journal of geophysical research. Space physics, 125(9), e2020JA028215. https://doi.org/10.1029/2020JA028215
Motoba, T, et al. "Dynamic Properties of Particle Injections Inside Geosynchronous Orbit: A Multisatellite Case Study." Journal of geophysical research. Space physics vol. 125,9 (2020): e2020JA028215. doi: https://doi.org/10.1029/2020JA028215
Motoba T, Ohtani S, Claudepierre SG, Reeves GD, Ukhorskiy AY, Lanzerotti LJ. Dynamic Properties of Particle Injections Inside Geosynchronous Orbit: A Multisatellite Case Study. J Geophys Res Space Phys. 2020 Sep;125(9):e2020JA028215. doi: 10.1029/2020JA028215. Epub 2020 Sep 17. PMID: 33282620; PMCID: PMC7685150.
Copy Download .nbib Format: NLM
Combined Spectroscopic Methods of Determination of Density of Electronic States: Comparative Analysis of Diffuse Reflectance Spectroelectrochemistry and Reversed Double-Beam Photoacoustic Spectroscopy.

The journal of physical chemistry letters

Kobielusz M, Nitta A, Macyk W, Ohtani B.
PMID: 33733790
J Phys Chem Lett. 2021 Mar 25;12(11):3019-3025. doi: 10.1021/acs.jpclett.1c00262. Epub 2021 Mar 18.

The diffuse reflectance spectroelectrochemistry (SE-DRS) and reversed double-beam photoacoustic spectroscopy (RDB-PAS) provide unique, complementary information on the density of electronic states (DOS) in the vicinity of the conduction band bottom. The measurements are performed under quite different conditions, representing...

Cite
Kobielusz M, Nitta A, Macyk W, et al. Combined Spectroscopic Methods of Determination of Density of Electronic States: Comparative Analysis of Diffuse Reflectance Spectroelectrochemistry and Reversed Double-Beam Photoacoustic Spectroscopy. J Phys Chem Lett. 2021;12(11):3019-3025doi: 10.1021/acs.jpclett.1c00262.
Kobielusz, M., Nitta, A., Macyk, W., & Ohtani, B. (2021). Combined Spectroscopic Methods of Determination of Density of Electronic States: Comparative Analysis of Diffuse Reflectance Spectroelectrochemistry and Reversed Double-Beam Photoacoustic Spectroscopy. The journal of physical chemistry letters, 12(11), 3019-3025. https://doi.org/10.1021/acs.jpclett.1c00262
Kobielusz, Marcin, et al. "Combined Spectroscopic Methods of Determination of Density of Electronic States: Comparative Analysis of Diffuse Reflectance Spectroelectrochemistry and Reversed Double-Beam Photoacoustic Spectroscopy." The journal of physical chemistry letters vol. 12,11 (2021): 3019-3025. doi: https://doi.org/10.1021/acs.jpclett.1c00262
Kobielusz M, Nitta A, Macyk W, Ohtani B. Combined Spectroscopic Methods of Determination of Density of Electronic States: Comparative Analysis of Diffuse Reflectance Spectroelectrochemistry and Reversed Double-Beam Photoacoustic Spectroscopy. J Phys Chem Lett. 2021 Mar 25;12(11):3019-3025. doi: 10.1021/acs.jpclett.1c00262. Epub 2021 Mar 18. PMID: 33733790; PMCID: PMC8041308.
Copy Download .nbib Format: NLM
Dual kinetics of OATP2B1: Inhibitory potency and pH-dependence of OATP2B1 inhibitors.

Drug metabolism and pharmacokinetics

Sato R, Akiyoshi T, Morita T, Katayama K, Yajima K, Kataoka H, Imaoka A, Ohtani H.
PMID: 34619547
Drug Metab Pharmacokinet. 2021 Dec;41:100416. doi: 10.1016/j.dmpk.2021.100416. Epub 2021 Aug 04.

Organic anion transporting polypeptide (OATP) 2B1 is expressed in the intestine and liver, and OATP2B1-mediated transport of estrone 3-sulfate is pH-dependent and consists of: the high-affinity component (Hc) and low-affinity component (Lc). This study aimed to evaluate the influence...

Cite
Sato R, Akiyoshi T, Morita T, et al. Dual kinetics of OATP2B1: Inhibitory potency and pH-dependence of OATP2B1 inhibitors. Drug Metab Pharmacokinet. 2021;41:100416doi: 10.1016/j.dmpk.2021.100416.
Sato, R., Akiyoshi, T., Morita, T., Katayama, K., Yajima, K., Kataoka, H., Imaoka, A., & Ohtani, H. (2021). Dual kinetics of OATP2B1: Inhibitory potency and pH-dependence of OATP2B1 inhibitors. Drug metabolism and pharmacokinetics, 41100416. https://doi.org/10.1016/j.dmpk.2021.100416
Sato, Ryo, et al. "Dual kinetics of OATP2B1: Inhibitory potency and pH-dependence of OATP2B1 inhibitors." Drug metabolism and pharmacokinetics vol. 41 (2021): 100416. doi: https://doi.org/10.1016/j.dmpk.2021.100416
Sato R, Akiyoshi T, Morita T, Katayama K, Yajima K, Kataoka H, Imaoka A, Ohtani H. Dual kinetics of OATP2B1: Inhibitory potency and pH-dependence of OATP2B1 inhibitors. Drug Metab Pharmacokinet. 2021 Dec;41:100416. doi: 10.1016/j.dmpk.2021.100416. Epub 2021 Aug 04. PMID: 34619547.
Copy Download .nbib Format: NLM
Risk factors for in-hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan.

Thoracic cancer

Shiraishi T, Oda K, Yamasaki K, Kido T, Sennari K, Mukae H, Ohtani M, Fujino Y, Matsuda S, Fushimi K, Yatera K.
PMID: 34865321
Thorac Cancer. 2022 Jan;13(2):236-246. doi: 10.1111/1759-7714.14254. Epub 2021 Dec 05.

BACKGROUND: The safety profile of systemic chemotherapy for lung cancer patients with interstitial pneumonia (IP) in clinical practice remains unclear. Using Diagnostic Procedure Combination (DPC) data from the Japanese administrative database, we investigated the mortality of hospitalized lung cancer...

Cite
Shiraishi T, Oda K, Yamasaki K, et al. Risk factors for in-hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan. Thorac Cancer. 2021;13(2):236-246doi: 10.1111/1759-7714.14254.
Shiraishi, T., Oda, K., Yamasaki, K., Kido, T., Sennari, K., Mukae, H., Ohtani, M., Fujino, Y., Matsuda, S., Fushimi, K., & Yatera, K. (2022). Risk factors for in-hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan. Thoracic cancer, 13(2), 236-246. https://doi.org/10.1111/1759-7714.14254
Shiraishi, Tomoko, et al. "Risk factors for in-hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan." Thoracic cancer vol. 13,2 (2022): 236-246. doi: https://doi.org/10.1111/1759-7714.14254
Shiraishi T, Oda K, Yamasaki K, Kido T, Sennari K, Mukae H, Ohtani M, Fujino Y, Matsuda S, Fushimi K, Yatera K. Risk factors for in-hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan. Thorac Cancer. 2022 Jan;13(2):236-246. doi: 10.1111/1759-7714.14254. Epub 2021 Dec 05. PMID: 34865321.
Copy Download .nbib Format: NLM
Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung.

Thoracic cancer

Ohtaki Y, Kaira K, Yajima T, Erkhem-Ochir B, Kawashima O, Kamiyoshihara M, Igai H, Onozato R, Ibe T, Kosaka T, Nakazawa S, Nagashima T, Oyama T, Shirabe K.
PMID: 34453496
Thorac Cancer. 2021 Oct;12(20):2666-2679. doi: 10.1111/1759-7714.14102. Epub 2021 Aug 28.

OBJECTIVES: Various drug-sensitivity markers have been reported to be associated with tumor progression and chemotherapy resistance. Detailed expression profiles of sensitivity markers for cytotoxic chemotherapy in pulmonary large cell neuroendocrine carcinoma (LCNEC) remain unclear. Herein, we aimed to clarify...

Cite
Ohtaki Y, Kaira K, Yajima T, et al. Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung. Thorac Cancer. 2021;12(20):2666-2679doi: 10.1111/1759-7714.14102.
Ohtaki, Y., Kaira, K., Yajima, T., Erkhem-Ochir, B., Kawashima, O., Kamiyoshihara, M., Igai, H., Onozato, R., Ibe, T., Kosaka, T., Nakazawa, S., Nagashima, T., Oyama, T., & Shirabe, K. (2021). Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung. Thoracic cancer, 12(20), 2666-2679. https://doi.org/10.1111/1759-7714.14102
Ohtaki, Yoichi, et al. "Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung." Thoracic cancer vol. 12,20 (2021): 2666-2679. doi: https://doi.org/10.1111/1759-7714.14102
Ohtaki Y, Kaira K, Yajima T, Erkhem-Ochir B, Kawashima O, Kamiyoshihara M, Igai H, Onozato R, Ibe T, Kosaka T, Nakazawa S, Nagashima T, Oyama T, Shirabe K. Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung. Thorac Cancer. 2021 Oct;12(20):2666-2679. doi: 10.1111/1759-7714.14102. Epub 2021 Aug 28. PMID: 34453496; PMCID: PMC8520808.
Copy Download .nbib Format: NLM
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Byrne KT, Betts CB, Mick R, Sivagnanam S, Bajor DL, Laheru DA, Chiorean EG, O'Hara MH, Liudahl SM, Newcomb C, Alanio C, Ferreira AP, Park BS, Ohtani T, Huffman AP, Väyrynen SA, Dias Costa A, Kaiser JC, Lacroix AM, Redlinger C, Stern M, Nowak JA, Wherry EJ, Cheever MA, Wolpin BM, Furth EE, Jaffee EM, Coussens LM, Vonderheide RH.
PMID: 34112709
Clin Cancer Res. 2021 Aug 15;27(16):4574-4586. doi: 10.1158/1078-0432.CCR-21-1047. Epub 2021 Jun 10.

PURPOSE: CD40 activation is a novel clinical opportunity for cancer immunotherapy. Despite numerous active clinical trials with agonistic CD40 monoclonal antibodies (mAb), biological effects and treatment-related modulation of the tumor microenvironment (TME) remain poorly understood.PATIENTS AND METHODS: Here, we...

Cite
Byrne KT, Betts CB, Mick R, et al. Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clin Cancer Res. 2021;27(16):4574-4586doi: 10.1158/1078-0432.CCR-21-1047.
Byrne, K. T., Betts, C. B., Mick, R., Sivagnanam, S., Bajor, D. L., Laheru, D. A., Chiorean, E. G., O'Hara, M. H., Liudahl, S. M., Newcomb, C., Alanio, C., Ferreira, A. P., Park, B. S., Ohtani, T., Huffman, A. P., Väyrynen, S. A., Dias Costa, A., Kaiser, J. C., Lacroix, A. M., Redlinger, C., Stern, M., Nowak, J. A., Wherry, E. J., Cheever, M. A., Wolpin, B. M., Furth, E. E., Jaffee, E. M., Coussens, L. M., & Vonderheide, R. H. (2021). Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(16), 4574-4586. https://doi.org/10.1158/1078-0432.CCR-21-1047
Byrne, Katelyn T, et al. "Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,16 (2021): 4574-4586. doi: https://doi.org/10.1158/1078-0432.CCR-21-1047
Byrne KT, Betts CB, Mick R, Sivagnanam S, Bajor DL, Laheru DA, Chiorean EG, O'Hara MH, Liudahl SM, Newcomb C, Alanio C, Ferreira AP, Park BS, Ohtani T, Huffman AP, Väyrynen SA, Dias Costa A, Kaiser JC, Lacroix AM, Redlinger C, Stern M, Nowak JA, Wherry EJ, Cheever MA, Wolpin BM, Furth EE, Jaffee EM, Coussens LM, Vonderheide RH. Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clin Cancer Res. 2021 Aug 15;27(16):4574-4586. doi: 10.1158/1078-0432.CCR-21-1047. Epub 2021 Jun 10. PMID: 34112709; PMCID: PMC8667686.
Copy Download .nbib Format: NLM
Showing 625 to 632 of 632 entries